**Biotech Startup Inks First Lease at Seaport District Conversion Project**
CBRE has announced it represented life sciences developer Phase 3 Real Estate Partners, Inc. in securing the first lease at GENESIS 12 Farnsworth, a recently converted brick-and-beam project located in Boston’s vibrant Seaport District.
CytoTronics, a company pioneering a semiconductor-based platform for cell biology research, has expanded into a 14,000-square-foot space within the building to accommodate its rapid growth.
“As a high-growth startup, it was essential for us to secure a flexible space near the Innovation District, a thriving hub for Boston’s leading tech and biotech companies,” said Jeffrey Abbott, co-founder and CEO of CytoTronics. “This new location supports our expansion with the necessary lab, office, and manufacturing facilities, while also providing an environment that will help us attract and retain top talent.”
Located at 12 Farnsworth Street, the GENESIS 12 Farnsworth property is one of ten GENESIS-branded properties in the Greater Boston area. Phase 3, a San Diego-based developer, also owns and operates GENESIS properties in both San Diego and the Bay Area.
This lease marks the latest milestone in the continual evolution of Boston’s Seaport District into a premier destination for biotechnology and innovation-focused companies.
